作为帕金森病治疗工具的CRISPR/sgRNA导向协同激活介质 (SAM)
Luis Fernando Narváez-Pérez1, Francisco Paz-Bermúdez1, José Arturo Avalos-Fuentes1
1Departamento de Fisiología, Biofísica y Neurociencias, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México, 07360, México.
Gene therapy
|August 4, 2023
概括
这项研究证明了使用CRISPR来使星球细胞产生多巴胺的帕金森病新型基因疗法. 这种方法成功地改善了大鼠模型中的运动功能.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,治疗选择有限.
- 基因疗法为PD试验治疗提供了一个有希望的途径.
- 开发恢复多巴胺生产的策略对于PD管理至关重要.
研究的目的:
- 测试CRISPR基因激活系统 (SAM) 对天体细胞内内源性多巴胺生成的疗效,用于PD治疗.
- 调查氨酸氧化酶基因 (th) 在星球细胞中激活以合成多巴胺 (DA).
- 评估DA产生天体细胞在PD的小鼠模型中的治疗潜力.
主要方法:
- 对单导向RNAs (sgRNAs) 的选,这些RNAs准了老鼠氨酸氧酶 (th) 促进体.
- 使用SAM系统验证C6质细胞中的Th蛋白表达.
- 通过伪lentivirus通过SAM和sgRNA转导大鼠天体细胞.
- 基因表达的量化,Th蛋白合成和DA释放 (HPLC).
- 植入DA生成天体细胞到6OHDA损伤的老鼠的条纹体.
主要成果:
- 成功的SAM诱导的Th蛋白表达和DA合成在培养的老鼠天体细胞中.
- 从工程天体细胞中释放DA的证明.
- 在接受DA生成天体细胞的受伤大鼠中,运动行为显著改善,运动不对称性减少.
- 对照组 (接受非DA生成天体细胞) 没有显示出运动改善.
结论:
- SAM CRISPR基因激活系统有效地诱导天体细胞中的内源性基因表达.
- 工程天体细胞可以成功地移植到大脑中产生多巴胺.
- 这种基因治疗方法显示出降低帕金森病中运动缺陷的潜力.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
299
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
299
Parkinson's Disease: Overview
598
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
598
CRISPR
52.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.3K
CRISPR/Cas9 Genome Editing
59
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
59
Alzheimer's Disease: Treatment
215
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
215
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K


